Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07648979
3D-Printed Resin Crowns vs Stainless Steel Crowns in Pulpotomized Primary Molars.Cairo UniversityNot Yet RecruitingNot Applicable
NCT07648979Not Yet Recruiting
Not Applicable
3D-Printed Resin Crowns vs Stainless Steel Crowns in Pulpotomized Primary Molars...Cairo University
NCT07647458
Quantifying Adhesive Residue on Skin Following Removal of Maxillofacial Prosthetic Adhesives: An In Vivo StudyAmrita Vishwa VidyapeethamCompletedNot Applicable
NCT07647458Completed
Not Applicable
Quantifying Adhesive Residue on Skin Following Removal of Maxillofacial Prosthet...Amrita Vishwa Vidyapeetha...
NCT07647874
Assessment of Spirulina Gel Prepared By Different Extraction Methods as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B PeriodontitisMansoura UniversityCompletedEarly Phase 1
NCT07647874Completed
Early Phase 1
Assessment of Spirulina Gel Prepared By Different Extraction Methods as an Adjun...Mansoura University
NCT07648745
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerAstraZenecaCompletedPhase 2
NCT07648745Completed
Phase 2
Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerAstraZeneca
NCT07648693
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET TrialResonova (Shanghai) Medtech LimitedRecruitingNot Applicable
NCT07648693Recruiting
Not Applicable
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System...Resonova (Shanghai) Medte...
NCT07647328
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerAstraZenecaNot Yet RecruitingPhase 3
NCT07647328Not Yet Recruiting
Phase 3
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2...AstraZeneca
NCT07648758
Produce Prescription for Healthy Blood PressureTexas A&M UniversityCompletedNot Applicable
NCT07648758Completed
Not Applicable
Produce Prescription for Healthy Blood PressureTexas A&M University
NCT07648667
Cognitive Task Sensitivity in Perimenopause and Nutritional StatusNorthumbria UniversityNot Yet Recruiting
NCT07648667Not Yet Recruiting
—
Cognitive Task Sensitivity in Perimenopause and Nutritional StatusNorthumbria University
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesCSL BehringNot Yet RecruitingPhase 3
NCT07648264Not Yet Recruiting
Phase 3
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to...CSL Behring
NCT07648485
Clinical Performance of CAD/CAM Hard Hybrid Ceramic Inlays Versus Resin Composite Inlays in Vital Molars With Extensive Occluso-Proximal Cavities: Two-Year Randomized Clinical TrialCairo UniversityNot Yet RecruitingNot Applicable
NCT07648485Not Yet Recruiting
Not Applicable
Clinical Performance of CAD/CAM Hard Hybrid Ceramic Inlays Versus Resin Composit...Cairo University
NCT07646678
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakedaNot Yet RecruitingPhase 2
NCT07646678Not Yet Recruiting
Phase 2
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakeda
NCT07647081
The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among WomenOklahoma State University Center for Health SciencesNot Yet RecruitingNot Applicable
NCT07647081Not Yet Recruiting
Not Applicable
The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among...Oklahoma State University...
NCT07647575
Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung DiseaseNational Science and Technology Council, TaiwanRecruitingNot Applicable
NCT07647575Recruiting
Not Applicable
Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung DiseaseNational Science and Tech...
NCT07646860
A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 2
NCT07646860Not Yet Recruiting
Phase 2
A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hy...Merck Sharp & Dohme LLC
NCT07648953
Microvideos for Improving HPV Vaccination Among Childhood Cancer SurvivorsHuntsman Cancer InstituteRecruitingNot Applicable
NCT07648953Recruiting
Not Applicable
Microvideos for Improving HPV Vaccination Among Childhood Cancer SurvivorsHuntsman Cancer Institute
NCT07647913
Rhythm Psychophysics With Parkinson's PatientsMcMaster UniversityNot Yet RecruitingNot Applicable
NCT07647913Not Yet Recruiting
Not Applicable
Rhythm Psychophysics With Parkinson's PatientsMcMaster University
NCT07648537
The Effect of Muscular Fatigue on Lower Limb Kinematics During Single-Leg Drop Landing in Female AthletesCairo UniversityNot Yet RecruitingNot Applicable
NCT07648537Not Yet Recruiting
Not Applicable
The Effect of Muscular Fatigue on Lower Limb Kinematics During Single-Leg Drop L...Cairo University
NCT07648381
Corpus Luteum Function and Cardiovascular Adaptation in a Natural MOCK Cycle.Universitair Ziekenhuis BrusselNot Yet Recruiting
NCT07648381Not Yet Recruiting
—
Corpus Luteum Function and Cardiovascular Adaptation in a Natural MOCK Cycle.Universitair Ziekenhuis B...
NCT07647497
Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary EmbolismSohag UniversityRecruiting
NCT07647497Recruiting
—
Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screen...Sohag University
NCT07647432
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIVPfizerNot Yet RecruitingPhase 2
NCT07647432Not Yet Recruiting
Phase 2
HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed...Pfizer
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting4 (20%)
not_applicable10 (50%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 32 (10%)
Early Phase 11 (5%)